Atai Life Sciences N.V.

NASDAQ: ATAI · Real-Time Price · USD
3.88
-0.13 (-3.24%)
At close: Aug 15, 2025, 3:59 PM
3.88
-0.13%
After-hours: Aug 15, 2025, 07:51 PM EDT

Atai Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.86M 308K 331K 378K 277K 314K 334K 271K 269K 232K 424K 666K 496K 20.38M 20.15M 19.88M 19.88M
Cost of Revenue
247K 330K 266K 340K 453K 537K 489K 451K 275K 168K 144K 108K 108K 48K 19K 19K 2.81M
Gross Profit
1.64M n/a 65K 38K -176K -223K -155K -180K -6K 64K 280K 558K 388K 20.33M 20.13M 19.86M 17.07M
Operating Income
-98.97M -102.58M -105.88M -110.11M -116.24M -124.79M -128.79M -140.38M -143.88M -144.79M -152.4M -147.34M -173.3M -135.81M -177.87M -151.89M -96.4M
Interest Income
657K 778K 1.24M 1.69M 1.88M 1.85M 1.38M 910K 724K 547K 485K 348K 266K 205K 94K 105K 88K
Pretax Income
-149.31M -148.68M -127.81M -57.5M -31.81M -39.29M -60.29M -137.27M -136.42M -135.18M -144.44M -137.78M -174.28M -136.6M -179.26M -174.12M -113.96M
Net Income
-148.99M -149.27M -128.6M -58.07M -33.8M -40.41M -67.44M -144.96M -142.77M -141.41M -184.97M -182.85M -200.46M -167.81M -165.53M -217.56M -185.46M
Selling & General & Admin
45.58M 47.44M 55.54M 58.91M 62.07M 63.58M 59.89M 65.67M 66.34M 70.35M 80.5M 81.34M 101.45M 92.75M 138.85M 122.92M 88.44M
Research & Development
55.25M 55.37M 50.48M 51.4M 54.27M 62.1M 69.92M 75.66M 78.13M 74.31M 71.97M 66.3M 64.38M 54.5M 38.33M 28.02M 14.85M
Other Expenses
5K n/a -116K -116K 88K 151K 262K 162K -54K -112K -112K -41K -29K -29K -29K n/a -1.3M
Operating Expenses
100.83M 102.81M 106.02M 110.3M 116.33M 125.68M 129.81M 141.34M 144.47M 144.66M 152.46M 147.64M 165.83M 147.25M 177.18M 150.94M 103.29M
Interest Expense
3.34M 3.12M 2.86M 2.77M 2.72M 2.66M 1.97M 1.28M 622K n/a n/a n/a n/a n/a 14K 14K 14K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
100.83M 102.89M 106.21M 110.49M 116.52M 125.78M 129.81M 141.34M 144.47M 144.66M 152.46M 147.64M 165.83M 147.25M 177.18M 150.94M 103.29M
Income Tax Expense
-196K -356K 265K 681K 847K 1.02M 6.59M 6.49M 6.35M 6.23M -4.19M -3.96M -3.95M -3.99M 733K 369K 9.67M
Shares Outstanding (Basic)
176.27M 160.16M 160.62M 160.39M 158.89M 158.84M 155.79M 155.79M 155.79M 158.7M 154.03M 153.97M 153.53M 150.06M 148.37M 132.27M 151.86M
Shares Outstanding (Diluted)
176.27M 160.16M 160.62M 160.39M 158.89M 158.84M 155.79M 155.79M 155.79M 158.7M 156.61M 153.97M 153.53M 151.13M 151.13M 132.27M 151.86M
EPS (Basic)
-0.91 -0.93 -0.81 -0.37 -0.22 -0.26 -0.43 -0.93 -0.92 -0.92 -1.22 -1.21 -1.38 -1.17 -1.15 -1.49 -1.23
EPS (Diluted)
-0.91 -0.93 -0.81 -0.37 -0.22 -0.26 -0.43 -0.92 -0.91 -0.91 -1.21 -1.21 -1.38 -1.17 -1.15 -1.49 -1.23
EBITDA
-145.32M -145.19M -124.71M -125.87M -100M -107.46M -127.44M -133.78M -133.76M -133.26M -134.35M -134.61M -157.16M -120.27M -156.99M -131.01M -83.38M
EBIT
-146.08M -145.66M -125.06M -54.85M -29.09M -36.63M -56.57M -134.23M -134.04M -133.43M -134.49M -134.72M -157.27M -120.33M -157.03M -131.06M -83.41M
Depreciation & Amortization
755K 473K 349K 340K 453K 537K 489K 451K 275K 168K 144K 101K 101K 47K 32K 44K 28K